Paul Edward Gross insider trades: Clovis Oncology (CLVS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2022 | CLVS | ↓ Sell | 4,730 | $0.98 | $5K | Direct | Nov 3, 2022 (1d) |
| Sep 2, 2022 | CLVS | ↓ Sell | 2,308 | $1.20 | $3K | Direct | Sep 6, 2022 (4d) |
| Aug 2, 2022 | CLVS | ↓ Sell | 4,807 | $1.46 | $7K | Direct | Aug 3, 2022 (1d) |
| Jun 2, 2022 | CLVS | ↓ Sell | 2,403 | $0.64 | $2K | Direct | Jun 3, 2022 (1d) |
| May 2, 2022 | CLVS | ↓ Sell | 4,570 | $1.97 | $9K | Direct | May 3, 2022 (1d) |
| Mar 2, 2022 | CLVS | ↓ Sell | 10,706 | $1.87 | $20K | Direct | Mar 3, 2022 (1d) |
| Feb 2, 2022 | CLVS | ↓ Sell | 5,436 | $1.94 | $11K | Direct | Feb 3, 2022 (1d) |
| Dec 2, 2021 | CLVS | ↓ Sell | 248 | $3.00 | $744 | Direct | Dec 3, 2021 (1d) |
| Nov 2, 2021 | CLVS | ↓ Sell | 4,523 | $4.55 | $21K | Direct | Nov 3, 2021 (1d) |
| Sep 2, 2021 | CLVS | ↓ Sell | 249 | $4.89 | $1K | Direct | Sep 3, 2021 (1d) |
| Aug 3, 2021 | CLVS | ↓ Sell | 4,507 | $4.82 | $22K | Direct | Aug 3, 2021 (0d) |
| Jun 3, 2021 | CLVS | ↓ Sell | 231 | $5.63 | $1K | Direct | Jun 3, 2021 (0d) |
| May 4, 2021 | CLVS | ↓ Sell | 4,838 | $5.54 | $27K | Direct | May 4, 2021 (0d) |
| Mar 2, 2021 | CLVS | ↓ Sell | 456 | $6.29 | $3K | Direct | Mar 3, 2021 (1d) |
| Feb 2, 2021 | CLVS | ↓ Sell | 11,873 | $7.97 | $95K | Direct | Feb 3, 2021 (1d) |
| Dec 3, 2020 | CLVS | ↓ Sell | 457 | $4.89 | $2K | Direct | Dec 7, 2020 (4d) |
| Nov 3, 2020 | CLVS | ↓ Sell | 2,534 | $4.93 | $12K | Direct | Nov 5, 2020 (2d) |
| Sep 3, 2020 | CLVS | ↓ Sell | 435 | $5.30 | $2K | Direct | Sep 8, 2020 (5d) |
| Aug 3, 2020 | CLVS | ↓ Sell | 2,506 | $5.92 | $15K | Direct | Aug 5, 2020 (2d) |
| Jun 3, 2020 | CLVS | ↓ Sell | 470 | $7.03 | $3K | Direct | Jun 5, 2020 (2d) |
| May 5, 2020 | CLVS | ↓ Sell | 2,213 | $8.10 | $18K | Direct | May 7, 2020 (2d) |
| Mar 3, 2020 | CLVS | ↓ Sell | 475 | $7.20 | $3K | Direct | Mar 5, 2020 (2d) |
| Feb 4, 2020 | CLVS | ↓ Sell | 10,470 | $8.41 | $88K | Direct | Feb 6, 2020 (2d) |
| Dec 3, 2019 | CLVS | ↓ Sell | 466 | $14.59 | $7K | Direct | Dec 5, 2019 (2d) |
| Sep 4, 2019 | CLVS | ↓ Sell | 495 | $5.21 | $3K | Direct | Sep 6, 2019 (2d) |
| Jun 4, 2019 | CLVS | ↓ Sell | 453 | $15.07 | $7K | Direct | Jun 6, 2019 (2d) |
| Mar 5, 2019 | CLVS | ↓ Sell | 1,325 | $29.29 | $39K | Direct | Mar 6, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Paul Edward Gross's insider trades
Paul Edward Gross is See Remarks at Clovis Oncology (CLVS). Since Mar 5, 2019, Paul has reported no open-market purchases and 27 sales worth $425K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (27 filings), grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.